IPO Boutique

GlycoMimetics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on GlycoMimetics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
GlycoMimeticsGLYC -
NASDAQ
$14.00-$16.00 $8.00 $10.407.0 million1/10/2014
Jefferies, Barclays
Co-Manager(s):
Stifel, Canaccord Genuity
Health Care
Filing(s):

Filed 2013-10-04



GlycoMimetics Quote & Chart - Click for current quote - GLYC

About GlycoMimetics (adapted from GlycoMimetics prospectus):
They are a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "GLYC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved